1 |
Zheng Y, Yu Y, Chen XF, Yang SL, Tang XL, Xiang ZG. Intestinal Macrophage Autophagy and its Pharmacological Application in Inflammatory Bowel Disease. Front Pharmacol 2021;12:803686. [PMID: 34899362 DOI: 10.3389/fphar.2021.803686] [Reference Citation Analysis]
|
2 |
Wang X, Zhou G, Zhou W, Wang X, Wang X, Miao C. Exosomes as a New Delivery Vehicle in Inflammatory Bowel Disease. Pharmaceutics 2021;13:1644. [PMID: 34683937 DOI: 10.3390/pharmaceutics13101644] [Reference Citation Analysis]
|
3 |
Jin J, Zhong Y, Long J, Wu T, Jiang Q, Wang H, Ge W, Zhao H, Liu D. Ginsenoside Rg1 relieves experimental colitis by regulating balanced differentiation of Tfh/Treg cells. Int Immunopharmacol 2021;100:108133. [PMID: 34543978 DOI: 10.1016/j.intimp.2021.108133] [Reference Citation Analysis]
|
4 |
Wei Z, Yuan J, Wang G, Ocansey DKW, Xu Z, Mao F. Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases. Stem Cells Int 2021;2021:5583994. [PMID: 33859701 DOI: 10.1155/2021/5583994] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
5 |
Zhang D, Lin Y, Li Y, Zhao D, Du M. Mesenchymal stem cells enhance Treg immunosuppressive function at the fetal-maternal interface. J Reprod Immunol 2021;148:103366. [PMID: 34492568 DOI: 10.1016/j.jri.2021.103366] [Reference Citation Analysis]
|
6 |
Chen YE, Xu SJ, Lu YY, Chen SX, Du XH, Hou SZ, Huang HY, Liang J. Asperuloside suppressing oxidative stress and inflammation in DSS-induced chronic colitis and RAW 264.7 macrophages via Nrf2/HO-1 and NF-κB pathways. Chem Biol Interact 2021;344:109512. [PMID: 33974900 DOI: 10.1016/j.cbi.2021.109512] [Reference Citation Analysis]
|
7 |
Wang R, Yao Q, Chen W, Gao F, Li P, Wu J, Yu J, Cao H. Stem cell therapy for Crohn's disease: systematic review and meta-analysis of preclinical and clinical studies. Stem Cell Res Ther 2021;12:463. [PMID: 34407875 DOI: 10.1186/s13287-021-02533-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
|